Association Between Domain‐Specific Physical Activity and Novel Inflammatory Biomarkers Among US Adults: Insights From NHANES 2007–2018
Objectives: The novel inflammatory biomarkers, including systemic immune‐inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil‐to‐lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activi...
Saved in:
Published in | Mediators of inflammation Vol. 2025; no. 1; p. 1989715 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.01.2025
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives: The novel inflammatory biomarkers, including systemic immune‐inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil‐to‐lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain‐specific moderate‐to‐vigorous‐intensity PA (MVPA) and these inflammatory biomarkers among US adults.
Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007–2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self‐reported MVPA. MVPA was categorized into three domains, including occupation‐related MVPA (O‐MVPA), transportation‐related MVPA (T‐MVPA), and leisure‐time‐related MVPA (LT‐MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain‐specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association.
Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT‐MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers ( β = −36, 95% confidence interval [CI]: −47 to −25, p < 0.001 for SII; β = −0.09, 95% CI: −0.13 to −0.05, p < 0.001 for SIRI; β = −0.08, 95% CI: −0.11 to −0.05, p < 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T‐MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels ( β = −17, 95% CI: −32 to −2.4, p = 0.023; β = −0.07, 95% CI: −0.11 to −0.03, p = 0.002). Conversely, O‐MVPA showed no significant correlation with any inflammatory biomarkers (all p > 0.05). No significant effect modification was observed in the association between LT‐MVPA or T‐MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT‐MVPA and T‐MVPA.
Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well‐established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. |
---|---|
AbstractList | The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults.
Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007-2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association.
The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers (
= -36, 95% confidence interval [CI]: -47 to -25,
< 0.001 for SII;
= -0.09, 95% CI: -0.13 to -0.05,
< 0.001 for SIRI;
= -0.08, 95% CI: -0.11 to -0.05,
< 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels (
= -17, 95% CI: -32 to -2.4,
=0.023;
= -0.07, 95% CI: -0.11 to -0.03,
=0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all
> 0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA.
The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults.Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007–2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association.Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers (β = −36, 95% confidence interval [CI]: −47 to −25, p <0.001 for SII; β = −0.09, 95% CI: −0.13 to −0.05, p <0.001 for SIRI; β = −0.08, 95% CI: −0.11 to −0.05, p <0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels (β = −17, 95% CI: −32 to −2.4, p=0.023; β = −0.07, 95% CI: −0.11 to −0.03, p=0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all p >0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA.Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults. Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007-2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association. Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines (≥150min/week) and circulating inflammatory biomarkers (β =-36, 95% confidence interval [CI]: -47 to -25, p<0.001 for SII; β =-0.09, 95% CI: -0.13 to -0.05, p<0.001 for SIRI; β =-0.08, 95% CI: -0.11 to -0.05, p<0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥150min/week) also exhibited lower SII and SIRI levels (β =-17, 95% CI: -32 to -2.4, p=0.023; β =-0.07, 95% CI: -0.11 to -0.03, p=0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all p>0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Keywords: leisure-time-related physical activity, lymphocytes ratio, NHANES, physical activity, systemic immune-inflammation index, systemic inflammation response index Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults. Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007–2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association. Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers ( β = −36, 95% confidence interval [CI]: −47 to −25, p < 0.001 for SII; β = −0.09, 95% CI: −0.13 to −0.05, p < 0.001 for SIRI; β = −0.08, 95% CI: −0.11 to −0.05, p < 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels ( β = −17, 95% CI: −32 to −2.4, p =0.023; β = −0.07, 95% CI: −0.11 to −0.03, p =0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all p > 0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults. Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007-2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association. Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers (β = -36, 95% confidence interval [CI]: -47 to -25, p < 0.001 for SII; β = -0.09, 95% CI: -0.13 to -0.05, p < 0.001 for SIRI; β = -0.08, 95% CI: -0.11 to -0.05, p < 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels (β = -17, 95% CI: -32 to -2.4, p=0.023; β = -0.07, 95% CI: -0.11 to -0.03, p=0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all p > 0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses.Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain-specific moderate-to-vigorous-intensity PA (MVPA) and these inflammatory biomarkers among US adults. Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007-2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self-reported MVPA. MVPA was categorized into three domains, including occupation-related MVPA (O-MVPA), transportation-related MVPA (T-MVPA), and leisure-time-related MVPA (LT-MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain-specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association. Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT-MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers (β = -36, 95% confidence interval [CI]: -47 to -25, p < 0.001 for SII; β = -0.09, 95% CI: -0.13 to -0.05, p < 0.001 for SIRI; β = -0.08, 95% CI: -0.11 to -0.05, p < 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T-MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels (β = -17, 95% CI: -32 to -2.4, p=0.023; β = -0.07, 95% CI: -0.11 to -0.03, p=0.002). Conversely, O-MVPA showed no significant correlation with any inflammatory biomarkers (all p > 0.05). No significant effect modification was observed in the association between LT-MVPA or T-MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT-MVPA and T-MVPA. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. Objectives: The novel inflammatory biomarkers, including systemic immune‐inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil‐to‐lymphocyte ratio (NLR), can contribute to predicting the future risk of various diseases. However, the impact of different physical activity (PA) domains on systemic inflammation remains unclear. The study aims to investigate the relationship between domain‐specific moderate‐to‐vigorous‐intensity PA (MVPA) and these inflammatory biomarkers among US adults. Methods: Participants from the US National Health and Nutrition Examination Survey (NHANES) (2007–2018) were included in this study. The Global Physical Activity Questionnaire was used to assess self‐reported MVPA. MVPA was categorized into three domains, including occupation‐related MVPA (O‐MVPA), transportation‐related MVPA (T‐MVPA), and leisure‐time‐related MVPA (LT‐MVPA). SII, SIRI, and NLR were derived from the complete blood count results obtained at the NHANES Mobile Examination Centers (MEC). Weighted multivariable linear regression and propensity score matching (PSM) were used to examine the relationship between domain‐specific MVPA and inflammatory biomarkers. Additionally, stratified and mediation analyses were performed to assess potential effect modifications and mediators in this association. Results: The study included a total of 29,072 participants. Following PSM, weighted multivariable linear regression indicated a negative association between LT‐MVPA meeting PA guidelines ( ≥ 150 min/week) and circulating inflammatory biomarkers ( β = −36, 95% confidence interval [CI]: −47 to −25, p < 0.001 for SII; β = −0.09, 95% CI: −0.13 to −0.05, p < 0.001 for SIRI; β = −0.08, 95% CI: −0.11 to −0.05, p < 0.001 for NLR, respectively), adjusting for all potential covariates in model 2. Participants engaging in sufficient T‐MVPA (≥ 150 min/week) also exhibited lower SII and SIRI levels ( β = −17, 95% CI: −32 to −2.4, p = 0.023; β = −0.07, 95% CI: −0.11 to −0.03, p = 0.002). Conversely, O‐MVPA showed no significant correlation with any inflammatory biomarkers (all p > 0.05). No significant effect modification was observed in the association between LT‐MVPA or T‐MVPA and inflammatory biomarkers (SII, SIRI, and NLR). Mediation analysis showed that body mass index (BMI) mediated the relationships between these inflammatory biomarkers and both LT‐MVPA and T‐MVPA. Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well‐established link between chronic inflammation and diseases such as cardiovascular disease (CVD), diabetes, and metabolic disorders, specific recommendations for PA categories should be provided, particularly targeting individuals with high systemic inflammatory responses. |
Audience | Academic |
Author | Yao, Kai Liu, Xin-ying |
AuthorAffiliation | 1 Endoscopy Center, Jinshan Hospital, Fudan University, Shanghai 201508, China 2 Department of Neurology, Jinshan Hospital, Fudan University, Shanghai 201508, China |
AuthorAffiliation_xml | – name: 1 Endoscopy Center, Jinshan Hospital, Fudan University, Shanghai 201508, China – name: 2 Department of Neurology, Jinshan Hospital, Fudan University, Shanghai 201508, China |
Author_xml | – sequence: 1 givenname: Xin-ying orcidid: 0009-0004-3876-8514 surname: Liu fullname: Liu, Xin-ying – sequence: 2 givenname: Kai orcidid: 0000-0001-7772-6991 surname: Yao fullname: Yao, Kai |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40599559$$D View this record in MEDLINE/PubMed |
BookMark | eNptksFuEzEURUeoiKaFDR-ALLFBSGltj-0Zs0HT0tJIVUAKXVsej504zNjBngRl1303lfjDfgkOCYUg5IXl5_OufZ_uUXbgvNNZ9hLBE4QoPe3sKeIlLxB9kg0QYWyISoYOsgHkDA95TtFhdhTjHEJICSmfZYcEUs4p5YPsrorRKyt76x040_13rR344Dtp3cPt_WShlTVWgc-zdbRKtqBSvV3Zfg2ka8DYr3QLRs60sutk78ManNnUG77qEEHVeTcFNxNQNcu2j-8SGO101kdwGXwHxlfV-GICMITFw-0PDFH5PHtqZBv1i91-nN1cXnw5vxpef_o4Oq-uh4pC1A81JzWrSVFLA2VpsGGkxAajQqkCcskRadKJq5wmhpiaM6OYYgaxopRM1flxNtrqNl7OxSLY9OO18NKKXwUfpkKG3qpWC2yIJJyzWnJFiMzrNNm8ULimHJaNIUnr_VZrsaw73Sjt-iDbPdH9G2dnYupXAmGMckhxUnizUwj-21LHXnQ2Kt220mm_jCLHmOW0ZBQm9PU_6Nwvg0uz2lAFoZzx_A81lcmBdcanh9VGVFQlYQUrOEWJOvkPlVajO6tSwIxN9b2GV387fbT4O0sJeLsFVPAxBm0eEQTFJqjJmNgFNf8JRmTZ9A |
Cites_doi | 10.1136/bjsports-2020-102587 10.1192/j.eurpsy.2022.2350 10.1097/00001648-200209000-00012 10.1016/j.it.2005.08.007 10.1186/s13075-023-03018-6 10.1016/j.bbi.2012.07.004 10.1038/s41598-019-39150-0 10.1177/0003319712455216 10.1016/0021-9150(90)90089-2 10.1002/acr.23855 10.1186/s40001-023-01529-1 10.1016/j.it.2014.02.008 10.1038/ijo.2011.50 10.1001/jama.2018.14854 10.1016/S2468-2667(18)30025-2 10.1016/j.amepre.2016.12.008 10.3945/an.115.009258 10.1016/S1074-7613(00)80334-9 10.1136/oemed-2019-106158 10.1097/JOM.0000000000002365 10.1136/bjsports-2022-105429 10.1016/S2213-8587(14)70134-2 10.1161/CIRCULATIONAHA.121.055716 10.1038/s41598-019-56218-z 10.3390/nu16060777 10.1186/s12967-023-04491-y 10.1016/j.immuni.2017.08.009 10.1136/bjsports-2017-097965 10.1056/NEJMoa1107477 10.1016/S2215-0366(21)00168-1 10.1186/s12889-024-19432-7 10.3389/fimmu.2022.1080782 10.1016/j.plefa.2024.102624 10.1158/1078-0432.CCR-14-0442 10.1093/eurheartj/ehab724.1353 10.2147/JIR.S283835 10.1046/j.1532-5415.2003.51380.x 10.1186/s12889-023-16358-4 10.1111/cns.14783 10.1007/s40279-018-0996-z 10.1016/j.redox.2024.103334 10.1093/eurpub/ckad213 10.1016/j.atherosclerosis.2010.07.002 10.1111/eci.12781 10.1111/j.1365-2796.2007.01766.x 10.1038/sj.ijo.0801583 10.1001/archinternmed.2011.2174 10.1016/j.joca.2011.02.016 10.1186/s12967-023-04566-w 10.3389/fimmu.2022.1034916 10.1186/s12889-025-21379-2 10.1017/S0954422410000016 10.1038/nrendo.2012.189 10.1172/JCI29881 10.1136/oemed-2020-106874 10.1017/S0029665111000565 10.3389/fimmu.2023.1175764 10.3390/jcm12031128 10.3109/07420528.2011.580869 10.1056/NEJMra043430 10.1093/aje/153.3.242 10.1249/MSS.0b013e3181a15512 10.1210/er.2002-0010 10.1093/eurheartj/ehab087 10.1007/s12035-015-9593-4 10.3389/fimmu.2022.925690 10.1097/MD.0000000000014834 10.1097/00003246-199904000-00026 10.1111/sms.12581 10.3389/fimmu.2023.1191130 10.1136/heartjnl-2022-321474 10.1016/j.bbi.2021.07.010 10.1371/journal.pone.0152339 10.3390/nu15051177 10.1186/s12966-020-00988-7 10.1016/j.molmet.2023.101755 10.3389/fcvm.2022.933913 10.1097/MCA.0000000000001037 10.3390/nu14153052 10.1097/00132580-200109000-00009 10.1371/journal.pone.0271238 10.1186/1475-2840-10-12 10.1002/j.2040-4603.2012.tb00425.x 10.1186/1479-5868-10-126 10.1146/annurev-publhealth-032315-021402 10.1139/apnm-2023-0550 10.3390/brainsci13020171 10.1038/jcbfm.2015.45 10.1136/bmj.38693.435301.80 10.3390/ijerph17165812 10.1146/annurev-immunol-031210-101322 10.3389/fpubh.2024.1197150 10.2337/dc18-2432 10.5271/sjweh.3965 10.4103/tjem.tjem_198_23 10.1016/j.beem.2010.07.001 |
ContentType | Journal Article |
Copyright | Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. COPYRIGHT 2025 John Wiley & Sons, Inc. Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (the “License”), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. 2025 |
Copyright_xml | – notice: Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. – notice: COPYRIGHT 2025 John Wiley & Sons, Inc. – notice: Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (the “License”), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 – notice: Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1155/mi/1989715 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1466-1861 |
Editor | Jasbir Arora (RSS) |
Editor_xml | – fullname: Jasbir Arora (RSS) |
ExternalDocumentID | oai_doaj_org_article_2f4a4996ba9c44a3b18637c2b5908df4 PMC12213052 A846767951 40599559 10_1155_mi_1989715 |
Genre | Journal Article |
GeographicLocations | United States United States--US |
GeographicLocations_xml | – name: United States – name: United States--US |
GroupedDBID | --- 0R~ 188 24P 29M 2UF 2WC 36B 4.4 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ 8G5 AAFWJ AAJEY AAMMB AAYXX ABDBF ABUWG ACCMX ACGFO ACIHN ACUHS ADBBV ADRAZ AEAQA AEFGJ AENEX AFKRA AFPKN AGXDD AHMBA AIDQK AIDYY AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC B0M BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CAG CCPQU CITATION COF CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HCIFZ HMCUK HYE IAO IGS IHR IL9 INH INR IPNFZ ITC KQ8 LK8 M1P M2O M48 M7P O5R O5S OK1 OVD OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RHU RIG RNS RPM SV3 TEORI TR2 TUS UKHRP UZ5 WOQ WOW ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c501t-e94b6b47baf0a8f2f6482f217cc709a914df219c3547b4fb96fc6c6f1678a6cb3 |
IEDL.DBID | M48 |
ISSN | 0962-9351 1466-1861 |
IngestDate | Wed Aug 27 00:42:10 EDT 2025 Thu Aug 21 18:33:40 EDT 2025 Fri Jul 11 16:56:56 EDT 2025 Sat Aug 23 13:23:39 EDT 2025 Thu Jul 10 07:44:02 EDT 2025 Tue Jul 08 03:51:50 EDT 2025 Mon Jul 21 06:02:01 EDT 2025 Thu Jul 03 08:37:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | systemic immune-inflammation index systemic inflammation response index NHANES lymphocytes ratio leisure-time-related physical activity physical activity |
Language | English |
License | Copyright © 2025 Xin-ying Liu and Kai Yao. Mediators of Inflammation published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c501t-e94b6b47baf0a8f2f6482f217cc709a914df219c3547b4fb96fc6c6f1678a6cb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Jasbir Arora (RSS) |
ORCID | 0009-0004-3876-8514 0000-0001-7772-6991 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/mi/1989715 |
PMID | 40599559 |
PQID | 3227459693 |
PQPubID | 2037497 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2f4a4996ba9c44a3b18637c2b5908df4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12213052 proquest_miscellaneous_3226358650 proquest_journals_3227459693 gale_infotracmisc_A846767951 gale_infotracacademiconefile_A846767951 pubmed_primary_40599559 crossref_primary_10_1155_mi_1989715 |
PublicationCentury | 2000 |
PublicationDate | 2025-01-01 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Mediators of inflammation |
PublicationTitleAlternate | Mediators Inflamm |
PublicationYear | 2025 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | e_1_2_13_24_2 e_1_2_13_47_2 e_1_2_13_26_2 e_1_2_13_45_2 e_1_2_13_68_2 e_1_2_13_20_2 e_1_2_13_43_2 e_1_2_13_66_2 e_1_2_13_87_2 Jin Z. (e_1_2_13_11_2) 2021; 14 e_1_2_13_22_2 e_1_2_13_41_2 e_1_2_13_64_2 e_1_2_13_85_2 e_1_2_13_8_2 e_1_2_13_62_2 e_1_2_13_83_2 e_1_2_13_6_2 e_1_2_13_60_2 e_1_2_13_81_2 e_1_2_13_90_2 e_1_2_13_92_2 e_1_2_13_94_2 e_1_2_13_96_2 Gregor M. F. (e_1_2_13_79_2) 2011; 29 e_1_2_13_17_2 e_1_2_13_38_2 e_1_2_13_19_2 e_1_2_13_13_2 e_1_2_13_59_2 e_1_2_13_15_2 e_1_2_13_36_2 e_1_2_13_57_2 e_1_2_13_78_2 e_1_2_13_30_2 e_1_2_13_55_2 e_1_2_13_76_2 e_1_2_13_32_2 e_1_2_13_53_2 e_1_2_13_74_2 e_1_2_13_51_2 e_1_2_13_72_2 e_1_2_13_70_2 e_1_2_13_4_2 e_1_2_13_2_2 e_1_2_13_88_2 e_1_2_13_27_2 e_1_2_13_29_2 e_1_2_13_23_2 e_1_2_13_48_2 e_1_2_13_69_2 e_1_2_13_25_2 e_1_2_13_46_2 e_1_2_13_67_2 e_1_2_13_44_2 e_1_2_13_65_2 e_1_2_13_21_2 e_1_2_13_42_2 e_1_2_13_63_2 e_1_2_13_61_2 e_1_2_13_84_2 e_1_2_13_7_2 e_1_2_13_40_2 e_1_2_13_82_2 e_1_2_13_5_2 e_1_2_13_80_2 e_1_2_13_9_2 e_1_2_13_91_2 e_1_2_13_93_2 e_1_2_13_95_2 Sagelv E. H. (e_1_2_13_86_2) 2021; 78 e_1_2_13_16_2 e_1_2_13_39_2 e_1_2_13_18_2 e_1_2_13_12_2 e_1_2_13_35_2 e_1_2_13_58_2 e_1_2_13_14_2 e_1_2_13_37_2 e_1_2_13_56_2 e_1_2_13_31_2 e_1_2_13_54_2 e_1_2_13_77_2 e_1_2_13_10_2 e_1_2_13_33_2 e_1_2_13_52_2 e_1_2_13_75_2 e_1_2_13_50_2 e_1_2_13_73_2 e_1_2_13_71_2 e_1_2_13_3_2 e_1_2_13_1_2 Pedersen B. K. (e_1_2_13_34_2) 2015; 25 e_1_2_13_28_2 e_1_2_13_89_2 e_1_2_13_49_2 |
References_xml | – ident: e_1_2_13_92_2 doi: 10.1136/bjsports-2020-102587 – ident: e_1_2_13_46_2 doi: 10.1192/j.eurpsy.2022.2350 – ident: e_1_2_13_59_2 doi: 10.1097/00001648-200209000-00012 – ident: e_1_2_13_4_2 doi: 10.1016/j.it.2005.08.007 – ident: e_1_2_13_22_2 doi: 10.1186/s13075-023-03018-6 – ident: e_1_2_13_64_2 doi: 10.1016/j.bbi.2012.07.004 – ident: e_1_2_13_94_2 doi: 10.1038/s41598-019-39150-0 – ident: e_1_2_13_12_2 doi: 10.1177/0003319712455216 – ident: e_1_2_13_2_2 doi: 10.1016/0021-9150(90)90089-2 – ident: e_1_2_13_73_2 doi: 10.1002/acr.23855 – ident: e_1_2_13_23_2 doi: 10.1186/s40001-023-01529-1 – ident: e_1_2_13_65_2 doi: 10.1016/j.it.2014.02.008 – ident: e_1_2_13_83_2 doi: 10.1038/ijo.2011.50 – ident: e_1_2_13_42_2 doi: 10.1001/jama.2018.14854 – ident: e_1_2_13_48_2 doi: 10.1016/S2468-2667(18)30025-2 – ident: e_1_2_13_93_2 doi: 10.1016/j.amepre.2016.12.008 – ident: e_1_2_13_37_2 doi: 10.3945/an.115.009258 – ident: e_1_2_13_70_2 doi: 10.1016/S1074-7613(00)80334-9 – ident: e_1_2_13_87_2 doi: 10.1136/oemed-2019-106158 – ident: e_1_2_13_84_2 doi: 10.1097/JOM.0000000000002365 – ident: e_1_2_13_36_2 doi: 10.1136/bjsports-2022-105429 – ident: e_1_2_13_81_2 doi: 10.1016/S2213-8587(14)70134-2 – ident: e_1_2_13_52_2 doi: 10.1161/CIRCULATIONAHA.121.055716 – ident: e_1_2_13_13_2 doi: 10.1038/s41598-019-56218-z – ident: e_1_2_13_56_2 doi: 10.3390/nu16060777 – ident: e_1_2_13_24_2 doi: 10.1186/s12967-023-04491-y – ident: e_1_2_13_78_2 doi: 10.1016/j.immuni.2017.08.009 – ident: e_1_2_13_29_2 doi: 10.1136/bjsports-2017-097965 – ident: e_1_2_13_17_2 doi: 10.1056/NEJMoa1107477 – ident: e_1_2_13_53_2 doi: 10.1016/S2215-0366(21)00168-1 – ident: e_1_2_13_45_2 doi: 10.1186/s12889-024-19432-7 – ident: e_1_2_13_44_2 doi: 10.3389/fimmu.2022.1080782 – ident: e_1_2_13_49_2 doi: 10.1016/j.plefa.2024.102624 – ident: e_1_2_13_8_2 doi: 10.1158/1078-0432.CCR-14-0442 – ident: e_1_2_13_26_2 doi: 10.1093/eurheartj/ehab724.1353 – volume: 14 start-page: 131 year: 2021 ident: e_1_2_13_11_2 article-title: The Associations of Two Novel Inflammation Indexes, Sii and Siri With the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-up Study in 85,154 Individuals publication-title: Journal of Inflammation Research doi: 10.2147/JIR.S283835 – ident: e_1_2_13_35_2 doi: 10.1046/j.1532-5415.2003.51380.x – ident: e_1_2_13_39_2 doi: 10.1186/s12889-023-16358-4 – ident: e_1_2_13_50_2 doi: 10.1111/cns.14783 – ident: e_1_2_13_66_2 doi: 10.1007/s40279-018-0996-z – ident: e_1_2_13_57_2 doi: 10.1016/j.redox.2024.103334 – ident: e_1_2_13_58_2 doi: 10.1093/eurpub/ckad213 – ident: e_1_2_13_67_2 doi: 10.1016/j.atherosclerosis.2010.07.002 – ident: e_1_2_13_68_2 doi: 10.1111/eci.12781 – ident: e_1_2_13_62_2 doi: 10.1111/j.1365-2796.2007.01766.x – ident: e_1_2_13_82_2 doi: 10.1038/sj.ijo.0801583 – ident: e_1_2_13_89_2 doi: 10.1001/archinternmed.2011.2174 – ident: e_1_2_13_72_2 doi: 10.1016/j.joca.2011.02.016 – ident: e_1_2_13_41_2 doi: 10.1186/s12967-023-04566-w – ident: e_1_2_13_15_2 doi: 10.3389/fimmu.2022.1034916 – ident: e_1_2_13_74_2 doi: 10.1186/s12889-025-21379-2 – ident: e_1_2_13_88_2 doi: 10.1017/S0954422410000016 – ident: e_1_2_13_77_2 doi: 10.1038/nrendo.2012.189 – ident: e_1_2_13_80_2 doi: 10.1172/JCI29881 – volume: 78 start-page: 203 year: 2021 ident: e_1_2_13_86_2 article-title: Do Declines in Occupational Physical Activity Contribute to Population Gains in Body Mass Index? Tromsø Study 1974–2016 publication-title: Occupational and Environmental Medicine doi: 10.1136/oemed-2020-106874 – ident: e_1_2_13_7_2 doi: 10.1017/S0029665111000565 – ident: e_1_2_13_9_2 doi: 10.3389/fimmu.2023.1175764 – ident: e_1_2_13_25_2 doi: 10.3390/jcm12031128 – ident: e_1_2_13_63_2 doi: 10.3109/07420528.2011.580869 – ident: e_1_2_13_5_2 doi: 10.1056/NEJMra043430 – ident: e_1_2_13_69_2 doi: 10.1093/aje/153.3.242 – ident: e_1_2_13_60_2 doi: 10.1249/MSS.0b013e3181a15512 – ident: e_1_2_13_75_2 doi: 10.1210/er.2002-0010 – ident: e_1_2_13_71_2 doi: 10.1093/eurheartj/ehab087 – ident: e_1_2_13_6_2 doi: 10.1007/s12035-015-9593-4 – ident: e_1_2_13_20_2 doi: 10.3389/fimmu.2022.925690 – ident: e_1_2_13_96_2 doi: 10.1097/MD.0000000000014834 – ident: e_1_2_13_95_2 doi: 10.1097/00003246-199904000-00026 – volume: 25 start-page: 1 year: 2015 ident: e_1_2_13_34_2 article-title: Exercise as Medicine - Evidence for Prescribing Exercise as Therapy in 26 Different Chronic Diseases publication-title: Scandinavian Journal of Medicine & Science in Sports doi: 10.1111/sms.12581 – ident: e_1_2_13_10_2 doi: 10.3389/fimmu.2023.1191130 – ident: e_1_2_13_30_2 doi: 10.1136/heartjnl-2022-321474 – ident: e_1_2_13_33_2 doi: 10.1016/j.bbi.2021.07.010 – ident: e_1_2_13_85_2 doi: 10.1371/journal.pone.0152339 – ident: e_1_2_13_21_2 doi: 10.3390/nu15051177 – ident: e_1_2_13_28_2 doi: 10.1186/s12966-020-00988-7 – ident: e_1_2_13_1_2 doi: 10.1016/j.molmet.2023.101755 – ident: e_1_2_13_19_2 doi: 10.3389/fcvm.2022.933913 – ident: e_1_2_13_16_2 doi: 10.1097/MCA.0000000000001037 – ident: e_1_2_13_47_2 doi: 10.3390/nu14153052 – ident: e_1_2_13_18_2 doi: 10.1097/00132580-200109000-00009 – ident: e_1_2_13_27_2 doi: 10.1371/journal.pone.0271238 – ident: e_1_2_13_61_2 doi: 10.1186/1475-2840-10-12 – ident: e_1_2_13_32_2 doi: 10.1002/j.2040-4603.2012.tb00425.x – ident: e_1_2_13_38_2 doi: 10.1186/1479-5868-10-126 – ident: e_1_2_13_54_2 doi: 10.1146/annurev-publhealth-032315-021402 – ident: e_1_2_13_55_2 doi: 10.1139/apnm-2023-0550 – ident: e_1_2_13_40_2 doi: 10.3390/brainsci13020171 – ident: e_1_2_13_3_2 doi: 10.1038/jcbfm.2015.45 – ident: e_1_2_13_90_2 doi: 10.1136/bmj.38693.435301.80 – ident: e_1_2_13_31_2 doi: 10.3390/ijerph17165812 – volume: 29 start-page: 415 year: 2011 ident: e_1_2_13_79_2 article-title: Inflammatory Mechanisms in Obesity publication-title: Annual Review of Immunology doi: 10.1146/annurev-immunol-031210-101322 – ident: e_1_2_13_51_2 doi: 10.3389/fpubh.2024.1197150 – ident: e_1_2_13_43_2 doi: 10.2337/dc18-2432 – ident: e_1_2_13_76_2 doi: 10.5271/sjweh.3965 – ident: e_1_2_13_14_2 doi: 10.4103/tjem.tjem_198_23 – ident: e_1_2_13_91_2 doi: 10.1016/j.beem.2010.07.001 |
SSID | ssj0005448 |
Score | 2.4001262 |
Snippet | Objectives: The novel inflammatory biomarkers, including systemic immune‐inflammation index (SII), systemic inflammation response index (SIRI), and... The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and... Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and... Objectives: The novel inflammatory biomarkers, including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and... Conclusions: The impact of different PA domains on systemic inflammation varies significantly. Given the well-established link between chronic inflammation and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1989715 |
SubjectTerms | Adult Adults Arthritis Asthma Biological markers Biomarkers Biomarkers - blood Biomarkers - metabolism Blood Blood tests Body mass index Bronchitis Cancer Carbohydrates Cardiovascular diseases Development and progression Diabetes Diabetes mellitus Disease Ethnicity Exercise Exercise - physiology Family income Female Humans Hyperlipidemia Hypertension Inflammation Inflammation - blood Inflammation - metabolism Leukocytes (neutrophilic) Lymphocytes Male Marital status Medical examination Medical laboratories Medical research Medicine, Experimental Metabolic disorders Microbiota Middle Aged Mortality Neutrophils Neutrophils - metabolism Nutrition Surveys Physical activity Physical fitness Questionnaires Stroke Surveys Surveys and Questionnaires Type 2 diabetes United States |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDxUXBOWVUpARSJyi5mE7NrcsdLUgdYVUVurNsp1YrCBJtbvlzJUz_5BfwoyTXSXiwIVj4nEUe8aeb5LxN4S8rgpeK-Z5rCRnMfNVElurTCxqb2thjBIeTyNfLsVixT5e8-tRqS_MCevpgfuJO888M4DKhTXKMWZym0qRFy6zWKy78oEJFHzePpjaJ3dA1DGQkYLDPG9gd1BSFVj8duR-Akv_33vxyBlNEyVHnmd-n9wbICMt-1d9QO7U7Qk5vhx-ij8kP0dTTGd93hV93zUQ88ehvLxfO_pp0ActXV8vgpq2osvue_2Nfmg92EUT_rfT2Rp6br4CKqQlFiKiqytaIknH9i0IbjGW39L5pmvoclEuL64ofob8_eMXuHj5iKzmF5_fLeKhwkLseJLuYlCTFZYV1vjESJ95wWTmIUpxrkiUUSmr4Eq5nIMM8xY054QTPgUXZ4Sz-WNy1HZt_ZRQB9tDBo-rROWYYxxxT5EkXppKQtRjI_JqP_H6pifS0CEA4Vw3az2oJyIz1MlBAsmvww0wCT2YhP6XSUTkDWpU4xIFtTkznDSAF0WyK10i5hIFYMuInE0kYWm5afPeJvSwtLcadsAChidUHpGXh2bsielqbd3dBhkAchLQb0Se9CZ0GBJDRhyI4yIiJ8Y1GfO0pV1_CcTfaZYB5ODZ6f-YpWfkboa1jMPnpDNytNvc1s8BYO3si7CW_gDNTiSO priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgkRCXFW8CCzICiVO0edhOzAWlsFVB2gppqdRbZDvxEkGS3abLmStn_iG_hBnX7TZC4pjYiZLM6xt7Mh8hr6uM15JZHsqcs5DZKgq1lioUtdW1UEoKi38jn87FbME-LfnSL7gNvqxy6xOdo656g2vkx6B4GeNSyPTdxWWIrFG4u-opNG6SW9i6DEu6smV2XeLBHHsWoPQklCmPfXtSCKHHLfgLmcsM6XD3ApLr2_-vd94LT-PSyb1YNL1LDj2IpMVG6vfIjbq7T26f-m3yB-TX3kenk00lFv3Qt6rpQkc4bxtDP3sJ0cJsGCSo6io673_U3-nHzoKmtG4Hnk4auHL1DXAiLZCaiC7OaIFtO4a3MHHA7H6g01Xf0vmsmJ-cUVyY_PPzNwT9_CFZTE--vJ-FnnMhNDyK1yEITgvNMq1spHKbWMHyxELeYkwWSSVjVsGRNCmHOcxqkKURRtgYgp4SRqePyEHXd_UTQg04jARuV4nKMAOyAySURZHNVZVDHqQD8mr74cuLTWuN0qUknJdtU3rxBGSCMtnNwHbY7kS_Oi-9dZWJZQpSN6GVNIypVMe5SDOTaGR0rywLyBuUaIlGC2Izyv97AA-K7a_KAlGYyABtBuRoNBOMzYyHtzpRemMfymvVDMjL3TBeiQVsXd1fuTkA7XLAwwF5vFGh3Ssx7JEDmV1A8pFyjd55PNI1X10r8DhJAITw5On_n-sZuZMgb7FbOjoiB-vVVf0cwNRav3AW8xc5Xx44 priority: 102 providerName: ProQuest |
Title | Association Between Domain‐Specific Physical Activity and Novel Inflammatory Biomarkers Among US Adults: Insights From NHANES 2007–2018 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40599559 https://www.proquest.com/docview/3227459693 https://www.proquest.com/docview/3226358650 https://pubmed.ncbi.nlm.nih.gov/PMC12213052 https://doaj.org/article/2f4a4996ba9c44a3b18637c2b5908df4 |
Volume | 2025 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwEB4tuxLignhvYKmMQOIUyMOPGAmhlG3VBbVasVTqLbKdGCq2CbRdBL-Av83YTUsjOHBMPK5qz4znG8eeD-BZKVglqWWhzBgNqS2jUGupQl5ZXXGlJLfuNvJ4wkdT-m7GZgew5e9sJ3D1z9TO8UlNl5cvfnz7-QYd_rV3eMZeLtD3ZSaFu2t-hBFJOAcd0z9Vwxn1LFqI1pNQpixuy5R2-3YCk6_f__cqvRemukco92LS8BbcbMEkyTfavw0HVX0Hro_bz-V34dfe5JP-5kQWOW0Wal6Hnnjezg05bzVFcrNhkiCqLsmk-V5dkrPaosUs_Jd40p9jz-UXxIskdxRFZHpBcle-Y_UKBVcuy1-R4bJZkMkonwwuiN-gxNCf3YPpcPDx7ShsmRdCw6J4HaL6NNdUaGUjldnEcpolFrMXY0QklYxpiU_SpAxlqNWoUcMNtzGGPsWNTu_DYd3U1TEQg8tGgj9X8tJQQ5nDQyKKbKbKDLMhHcDT7bQXXzcFNgqfmDBWLOZFq5wA-k4jOwlXFNu_aJafitbHisRShQkc10oaSlWq44ynwiTa8bqXlgbw3OmzcMaESjOqvYGAf9QVwSpyh8W4QMwZwElHEl3OdJu3FlFsLbbAlVHg8LhMA3iya3Y93TG2umquvAwCvAxRcQAPNga0GxJ1lXIwvwsg65hWZ8zdlnr-2RcEj5MEoQhLHv73AB_BjcQRGfu9pBM4XC-vqseIrta6B9fETPTgqD-YnH_Ap9Oz9z2_U9HzTvUbQbMmzA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuiDeGAosAcbJqr9drLxJCDk2U0MaqaCP1ZnbXXoggdklSEDeunPkf_Ch-CbO2kyZC4tajvWNr7XnsN_uYD-BZHoWFYCZ0RRwyl5ncc5US0uWFUQWXUnBjTyOPUj4Ys7cn4ckW_F6ehbHbKpcxsQ7UeaXtHPkuGl7EQsFF8Pr0i2tZo-zq6pJCozGL_eL7N0zZ5q-Ge6jf55T2e8dvBm7LKuDq0PMXLnZNccUiJY0nY0MNZzE1iMy1jjwhhc9yvBI6CFGGGYW91Vxz42NYl1yrAN97CbZZgKlMB7a7vfTw3fmmElbzdWFeQF0RhH5bEBUH7d0pRigRi8gS8K4NgTVTwL_jwdqAuLlZc23061-Hay1sJUljZzdgqyhvwuVRuzB_C36uqZl0m71fZK-ayknp1hT3ZqLJYWsTJNENZwWRZU7S6mvxmQxLg7Y5rdf8SXeCT84-ITIliSVDIuMjkthCIfOXKDi38wlz0p9VU5IOkrR3ROxU6J8fvxBmxLdhfCH6uAOdsiqLe0A0hiiKr8t5rplGa0HsFXmeiWUeY-alHHi6_PHZaVPMI6uToDDMppOsVY8DXauTlYQtwF3fqGYfstafM2qYxGSRKyk0YzJQfsyDSFNlOeRzwxx4YTWa2TCBatOyPe2AHbUFt7LE4j4eIb51YGdDEt1bbzYvbSJrw8s8O3cGB56smu2TdstcWVRntQyCyRgRuAN3GxNafRKzVXkwl3Qg3jCujW_ebCknH-vi4z6lCHtCev___XoMVwbHo4PsYJjuP4Cr1LIm1xNXO9BZzM6KhwjlFupR6z8E3l-0y_4F6EJdGQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Pb9MwFLfGkCYuiP8EBhgB4hQ1cRw7RkIopataxqpJo1JvxnZiiKDJaDsQN66c-TZ8HD4Jz0naNULitmNiJ3Ly_vj37Of3Q-hpxuNcUBv7IompT20W-FoL5bPc6pwpJZh1p5GPJmw0pW9m8WwH_V6fhXFplWufWDvqrDJujbwHisdpLJiIerZNizgeDF-dfvEdg5TbaV3TaTQqcph__wbh2_LleACyfkbI8ODd65HfMgz4Jg7ClQ_D1ExTrpUNVGKJZTQhFlC6MTwQSoQ0gythohj6UKth5IYZZkNw8YoZHcF7L6HLPIpDZ2N8xs_TS2jN3AURAvEFtLelUWH67s3BV4lEcEfFuzUZ1pwB_84MW1NjN21zax4cXkNXWwCL00bjrqOdvLyB9o7aLfqb6OeWwHG_yQLDg2quitKvye5tYfBxqx04NQ17BVZlhifV1_wzHpcWtHRe7_7jfgFPLj4BRsWpo0XC0xOcupIhyxfQcelWFpZ4uKjmeDJKJwcn2C2K_vnxCwBHcgtNL0Qat9FuWZX5XYQNOCsCr8tYZqgBvQEUxoPAJipLIAbTHnqy_vHytCnrIetwKI7lvJCteDzUdzLZ9HCluOsb1eKDbC1bEksVhI1MK2EoVZEOExZxQ7Rjk88s9dBzJ1HpHAaIzaj23AMM1JXekqlDgIwD0vXQfqcnGLrpNq91QraOZinPzcJDjzfN7kmXPFfm1VndB2BlAljcQ3caFdp8EnX1eSCq9FDSUa7ON3dbyuJjXYY8JAQAUEzu_X9cj9AeGKp8O54c3kdXiKNPrlew9tHuanGWPwBMt9IPa-PB6P1FW-tfOwJf6Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+Between+Domain-Specific+Physical+Activity+and+Novel+Inflammatory+Biomarkers+Among+US+Adults%3A+Insights+From+NHANES+2007-2018&rft.jtitle=Mediators+of+inflammation&rft.au=Liu%2C+Xin-ying&rft.au=Yao%2C+Kai&rft.date=2025-01-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0962-9351&rft.volume=2025&rft_id=info:doi/10.1155%2Fmi%2F1989715&rft.externalDocID=A846767951 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon |